A xenograft mouse model of GAS5 overexpression (OE), GAS5 OE plus gefitinib, gefitinib alone, or vehicle, showed that GAS5 OE plus gefitinib yielded the best tumor size reduction outcomes. This evidence concerns the gene GAS5 and neoplasm.